Verax Secures $7.6 Million in Seed Funding for Cutting-Edge Animal Health Decision-Making Platform

We are thrilled to announce that Verax, a pioneering data-driven decision-making tool for the veterinary and nutrition sectors, has successfully raised $7.6 million in funding. This significant investment will be instrumental in advancing our mission to enhance animal health and performance through data-driven insights. At Verax, we believe that timely and accurate information is crucial for making informed decisions about animal care. Our innovative platform leverages blood biomarkers, the gold standard for early detection of hidden performance issues, to empower veterinarians, nutritionists, and operations with the knowledge they need. With this funding, we aim to expand our cutting-edge technology and proprietary benchmarking data that allows users to effortlessly compare their health metrics against industry averages, thus enabling them to take proactive measures in animal health management. The support of our investors will also enable us to further develop our platform’s capabilities, enhancing user experience and expanding our customer base. Verax is a proud initiative from DSM Nutritional Products, LLC, and we remain committed to bringing the best solutions to the market to revolutionize animal health care. We are excited about the journey ahead and the potential to make a meaningful impact on the industry. Together, we can help ensure that animals receive the optimal care they deserve, leading to healthier populations and improved overall outcomes in animal health. Thank you for joining us on this exciting journey toward transforming animal health through data-driven decision-making.